Lozada, Elenita D.
HRN: 25-48-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTRIAXONE 1G (VIAL)
04/06/2026
04/13/2026
IV
2g
Q24
T/c Enterocutaneous Fistula
Checking Initial Appropriateness
04/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2026
04/13/2026
IV
500mg
Q8
T/c Enterocutaneous Fistula
Checking Initial Appropriateness
04/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/07/2026
04/14/2026
IV
2.25grams
Q8H
S/P ExLap Sigmoid Adenocarcinoma
Checking Initial Appropriateness